PWG
GILD icon

Portside Wealth Group’s Gilead Sciences GILD Stock Holding History

Portside Wealth Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
15,449
-171
-1% -$22.5K 0.23% 93
2026
Q1 		$2.18M Sell
15,620
-1,130
-7% -$158K 0.29% 79
2025
Q4 		$2.06M Sell
16,750
-991
-6% -$120K 0.28% 80
2025
Q3 		$1.97M Buy
17,741
+286
+2% +$32.5K 0.27% 85
2025
Q2 		$1.94M Buy
17,455
+621
+4% +$66.1K 0.29% 78
2025
Q1 		$1.89M Buy
16,834
+373
+2% +$38.5K 0.31% 78
2024
Q4 		$1.52M Sell
16,461
-946
-5% -$85.2K 0.25% 91
2024
Q3 		$1.46M Buy
17,407
+1,827
+12% +$139K 0.25% 96
2024
Q2 		$1.07M Sell
15,580
-514
-3% -$34.3K 0.2% 117
2024
Q1 		$1.18M Sell
16,094
-316
-2% -$24.3K 0.22% 112
2023
Q4 		$1.33M Buy
16,410
+7,262
+79% +$565K 0.25% 99
2023
Q3 		$685K Buy
9,148
+78
+0.9% +$6K 0.13% 158
2023
Q2 		$699K Buy
+9,070
New +$723K 0.13% 162

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Portside Wealth Group's GILD Position: Q2 2026 in Review

Portside Wealth Group reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $22.5K and leaving 15,449 shares worth $1.95M. The position accounts for 0.23% of the portfolio, ranked #93.

Portside Wealth Group first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.18M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Portside Wealth Group held 15,449 shares of Gilead Sciences worth $1.95M as of Q2 2026.
  • Portside Wealth Group sold 171 Gilead Sciences shares in Q2 2026, an estimated $22.5K.
  • Gilead Sciences made up 0.23% of Portside Wealth Group's portfolio in Q2 2026, its #93 holding.
  • Portside Wealth Group first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • Portside Wealth Group's Gilead Sciences position peaked at $2.18M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.